溶性环氧化酶删除在自闭症动物中通过AMPK-mTOR通路挽救行为和突触缺陷
Ming-Chia Chu1, Han-Fang Wu2, Chi-Wei Lee1
1Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Progress in neuro-psychopharmacology & biological psychiatry
|November 7, 2024
概括
溶性环氧化酶 (sEH) 缺乏改善了氨酸诱导的自闭症谱系障碍 (ASD) 鼠标模型中的社会缺陷和突触可塑性. 这表明sEH是ASD的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 遗传学 遗传学 是一个
背景情况:
- 自闭症谱系障碍 (ASD) 涉及社会缺陷和突触功能障碍.
- 溶性环氧化酶 (sEH) 与各种病理状况有关.
- 在ASD的突触缺陷中sEH的作用仍然不清楚.
研究的目的:
- 为了研究 sEH 缺乏对氨酸 (VPA) 诱导的 ASD 鼠标模型中的突触缺陷的影响.
- 探索涉及AMPK-mTOR通路的潜在机制.
主要方法:
- 使用了一种经过VPA治疗的小鼠模型,具有遗传性SEH淘汰.
- 评估了社会行为,恐惧学习和记忆灭绝.
- 进行了电生理学评估,以评估突触可塑性.
- 分析了AMPK-mTOR路径.
主要成果:
- VPA治疗增加了前额叶皮层中的SEH表达.
- 在接受VPA治疗的小鼠中,遗传sEH删除改善了社会缺陷和恐惧记忆灭绝.
- sEH删除特别改善了长期的突触可塑性,而不是突触前效率.
- 在SEH被删除的VPA治疗小鼠中,AMPK-mTOR通路被恢复.
结论:
- sEH在与ASD相关的突触功能障碍中发挥着关键作用.
- 通过AMPK-mTOR通路,sEH缺乏改善了类似ASD的行为和突触缺陷.
- 准sEH为ASD提供了一个新的治疗策略.
相关概念视频
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...


